https://www.selleckchem.com/pr....oducts/lomerizine-hc
anoma patients randomized to the ASICA intervention were able to report skin-related concerns that could be resolved remotely through interaction with a DNP. Feasibility issues highlighted by ASICA will support further development and optimization of this digital tool. Clinical Trials.gov , NCT03328247 . Registered on 1 November 2017. Clinical Trials.gov , NCT03328247 . Registered on 1 November 2017. Studies have shown that the Sec61 gamma subunit (SEC61G) is overexpressed in several tumors and could serve as a potential prognost
Me gusta
Comentario
Compartir
